| |
|
| 10 October 2025 |
Guidance updated to reflect BNF 90 and BNFC 2025-2026
Changes are:
- Glyceryl trinitrate spray – updated information on administration: repeat dose changed from 'after 3 minutes' to 'after 5 minutes'.
- Ibuprofen – addition of information on maximum dose in children.
- Metronidazole – update to patient advice on alcohol use during and after treatment.
- Miconazole Oromucosal Gel – change in pack size from 80 g to 15 g.
- Omeprazole – Removed cautions on use during pregnancy and breast-feeding.
- Salbutamol – updated information on administration.
|
| 4 June 2025 |
Guidance updated to reflect BNF 89
Changes are:
- Co-amoxiclav - change to expression of co-amoxiclav tablet dose from 250/125 to 375 mg (250/125 mg)
- Fungal infections - section updated to reflect changes to fluconazole dosing and management of oropharyngeal fungal infections
- Glucose - change to glucose doses for treatment of hypoglycaemia in adults and children
|
| 11 December 2024 |
Guidance updated to reflect BNF 88 and BNFC 2024-25 |
| 3 June 2024 |
Guidance updated to reflect BNF 87 and BNFC 2023-24
Changes are:
- BioXtra Gel - preparation removed as no longer listed in BNF
- Doxycyline - change of duration for treatment of sinusitis from 7 days to 5 days
- Loratidine - update to child age/weight dosing information
- Paracetamol - update to presentation of child age ranges
|
|
8 April 2024
|
Miconazole cream - tube size amended from 20 g to 30 g
|
|
9 November 2023
|
Ephedrine Nasal Drops, 0.5% - preparation removed as no longer available to prescribe.
|